366 related articles for article (PubMed ID: 17400544)
1. Cell phenotype-specific down-regulation of Smad3 involves decreased gene activation as well as protein degradation.
Poncelet AC; Schnaper HW; Tan R; Liu Y; Runyan CE
J Biol Chem; 2007 May; 282(21):15534-40. PubMed ID: 17400544
[TBL] [Abstract][Full Text] [Related]
2. NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-β1/Smad3 pathway.
Jin Z; Gu C; Tian F; Jia Z; Yang J
Cell Tissue Res; 2017 Sep; 369(3):603-610. PubMed ID: 28646304
[TBL] [Abstract][Full Text] [Related]
3. Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor.
Lin SL; Chen RH; Chen YM; Chiang WC; Lai CF; Wu KD; Tsai TJ
J Am Soc Nephrol; 2005 Sep; 16(9):2702-13. PubMed ID: 15987746
[TBL] [Abstract][Full Text] [Related]
4. Effects of proteasome inhibitors on rat renal fibrosis in vitro and in vivo.
Sakairi T; Hiromura K; Takahashi S; Hamatani H; Takeuchi S; Tomioka M; Maeshima A; Kuroiwa T; Nojima Y
Nephrology (Carlton); 2011 Jan; 16(1):76-86. PubMed ID: 21175982
[TBL] [Abstract][Full Text] [Related]
5. WNT/β-catenin signal inhibitor IC-2-derived small-molecule compounds suppress TGF-β1-induced fibrogenic response of renal epithelial cells by inhibiting SMAD2/3 signalling.
Hoi S; Tsuchiya H; Itaba N; Suzuki K; Oka H; Morimoto M; Takata T; Isomoto H; Shiota G
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):940-946. PubMed ID: 32012313
[TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-β/Smad pathway in renal proximal tubular epithelial cells.
Wang YN; Zhao SL; Su YY; Feng JX; Wang S; Liao XM; Wang LN; Li JC; Meng P; Li HY; Zhang YF
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515466
[TBL] [Abstract][Full Text] [Related]
7. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
8. Smad2 and Smad3 play antagonistic roles in high glucose-induced renal tubular fibrosis via the regulation of SnoN.
Wang Y; Zhang X; Mao Y; Liang L; Liu L; Peng W; Liu H; Xiao Y; Zhang Y; Zhang F; Shi M; Liu L; Guo B
Exp Mol Pathol; 2020 Apr; 113():104375. PubMed ID: 31917288
[TBL] [Abstract][Full Text] [Related]
9. Klotho down-regulates Egr-1 by inhibiting TGF-β1/Smad3 signaling in high glucose treated human mesangial cells.
Li Y; Hu F; Xue M; Jia YJ; Zheng ZJ; Wang L; Guan MP; Xue YM
Biochem Biophys Res Commun; 2017 May; 487(2):216-222. PubMed ID: 28411025
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression.
Luo DD; Phillips A; Fraser D
Am J Pathol; 2010 Mar; 176(3):1139-47. PubMed ID: 20093492
[TBL] [Abstract][Full Text] [Related]
11. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
12. Polarity of response to transforming growth factor-beta1 in proximal tubular epithelial cells is regulated by beta-catenin.
Zhang M; Lee CH; Luo DD; Krupa A; Fraser D; Phillips A
J Biol Chem; 2007 Sep; 282(39):28639-28647. PubMed ID: 17623674
[TBL] [Abstract][Full Text] [Related]
13. Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP).
Zhou B; Liu Y; Kahn M; Ann DK; Han A; Wang H; Nguyen C; Flodby P; Zhong Q; Krishnaveni MS; Liebler JM; Minoo P; Crandall ED; Borok Z
J Biol Chem; 2012 Mar; 287(10):7026-38. PubMed ID: 22241478
[TBL] [Abstract][Full Text] [Related]
14. Norcantharidin inhibits renal interstitial fibrosis by blocking the tubular epithelial-mesenchymal transition.
Li Y; Sun Y; Liu F; Sun L; Li J; Duan S; Liu H; Peng Y; Xiao L; Liu Y; Xi Y; You Y; Li H; Wang M; Wang S; Hou T
PLoS One; 2013; 8(6):e66356. PubMed ID: 23825538
[TBL] [Abstract][Full Text] [Related]
15. Pirfenidone Attenuates Renal Tubulointerstitial Fibrosis through Inhibiting miR-21.
Bi L; Huang Y; Li J; Yang X; Hou G; Zhai P; Zhang Q; Alhaji AA; Yang Y; Liu B
Nephron; 2022; 146(1):110-120. PubMed ID: 34724669
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
Yang F; Chung AC; Huang XR; Lan HY
Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor β1 antagonizes the transcription, expression and vascular signaling of guanylyl cyclase/natriuretic peptide receptor A - role of δEF1.
Sen A; Kumar P; Garg R; Lindsey SH; Katakam PV; Bloodworth M; Pandey KN
FEBS J; 2016 May; 283(9):1767-81. PubMed ID: 26934489
[TBL] [Abstract][Full Text] [Related]
18. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
19. Notch4-dependent antagonism of canonical TGF-β1 signaling defines unique temporal fluctuations of SMAD3 activity in sheared proximal tubular epithelial cells.
Grabias BM; Konstantopoulos K
Am J Physiol Renal Physiol; 2013 Jul; 305(1):F123-33. PubMed ID: 23576639
[TBL] [Abstract][Full Text] [Related]
20. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
